Charite-Universitätsmedizin Berlin - Berlin

Berlin 13353

0 studies enrolling now · 3 studies all time

What they study most

Colitis, Ulcerative, Crohn Disease, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Studies at this site

• A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease — Completed
• A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC) — Completed
• A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma — Completed